Home Companies Henan Lantian Medical Supplies Co.,Ltd.

60ul Sample Troponin I Rapid Test Kit

Henan Lantian Medical Supplies Co.,Ltd.
Active Member

Contact Us

[China] country

Address: Office Address: Building 4, No. 51 Jingbei 3rd Road, Jingkai Zone, Zhengzhou City. Henan Province,China.

Contact name:chen

Inquir Now

Henan Lantian Medical Supplies Co.,Ltd.

60ul Sample Troponin I Rapid Test Kit

Country/Region china
City & Province zhengzhou henan
Categories Dyestuff Intermediates
InquireNow

Product Details

Combined Detection Reagent Of Troponin I,Myoglobin And Creatine Kinase Isoenzyme(CTnl/MYO/CK-MB)

 

CTnI/MYO/CK-MB Overview


Cardiac troponin I/myoglobin/creatine kinase isoenzyme (cTnI/myo/CK-MB) includes the detection of the following three indicators: cardiac troponin I (cTnI), myoglobin (myo), creatine kinase isoenzyme (CK-MB). The combined detection of these three indicators is of great significance in the early diagnosis of acute myocardial diseases such as acute myocardial infarction (AMI).

 

American Academy of Clinical Biochemical Sciences (Nacb) practice guide

Myocardial necrosis markers should be detected in all suspected ACS patients
Troponin is the first choice for the diagnosis of myocardial infarction
Myoglobin combined with specific markers of myocardial necrosis (such as cTnI/CK-MB) is helpful to more quickly exclude or diagnose myocardial infarction

 

 

 MYOCK-MBcTnI
molecular weight17.8KD86KD22.5KD
Rise time1-2h4-6h3-6h
Peak time6-9h24h12-16h
recovery time18-30h2-3d4-10d
Clinical value1. The most important index of AMI early exclusion
2. The best index of AMI recurrence diagnosis and reperfusion treatment effect evaluation
1. Estimate infarct size or reinfarction
2. The most valuable marker of non ST segment elevation MI
1. The first choice marker for AMI diagnosis
2. Determine the infarct size and make risk stratification

 

 

CTnI/MYO/CK-MB Clinical Significance


  • It is helpful for early diagnosis and risk stratification of acute coronary syndrome
  • The area of myocardial ischemia injury was determined
  • Differential diagnosis of various causes of chest pain
  • Monitoring of myocardial injury caused by various causes
  • Clinical evaluation of some therapeutic drugs

 

Possibility of outcome 
cTnICK-MBMYOClinical possibility

+

++Myocardial infarction / myocardial injury can be diagnosed basically, and the occurrence time is within 12-24 hours;
++-Basically, it can be diagnosed as myocardial infarction / myocardial injury, and the detection time is more than 1 day, which has passed the detection window period of myo;
+--Myocardial infarction / myocardial injury has occurred for 2-3 days, it is recommended to reexamine after a few hours;
+-+In patients with myocardial infarction / myocardial injury, the detection time may be more than 3 days, and the patients may have re injury or enlarged infarct size;
-++For early myocardial infarction / myocardial injury / muscle injury, cTnI should be reexamined within 4-8 hours;

-

-+1. Early myocardial infarction / myocardial injury, cTnI should be reexamined within 4-8 hours;
2. It may be caused by other injury diseases, such as creation, skeletal muscle injury, liver and kidney disease;
-+-1. Minor myocardial injury, cTnI should be reexamined within 4-8 hours;
2. It may be a non myocardial injury disease, and the detection time has passed the myo window;

-

--Myocardial infarction / myocardial injury is basically ruled out. If it is highly suspected, reexamination is recommended every 2-4 hours.

 

 

cTnI/MYO/CK-MB Performance Index


Detection rangesample sizeSample typeTest time
cTnIMYOCK-MB60μlWhole blood / serum / plasma15min
0.1~50ng/mL10~200ng/mL0.8~100ng/mL

 

 

 

Application Department


Outpatient, emergency, physical examination center, cardiovascular, ICU, chest pain center and other departments

 

 

CTnI/MYO/CK-MB Clinical Comparison


 

 

Company profile


ZOS-F2100(Multi-Channel) 4ZOS-F2100(Multi-Channel) 5ZOS-F2100(Multi-Channel) 6ZOS-F2100(Multi-Channel) 7

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

 

 

 

 

Hot Products

Heart Type Fatty Acid Binding Protein Detection Reagent(H-FABP) H-FABP Overview H-FABP mainly exists ...
0.1~10mg/L D-Dimer Detection Reagent(D-Dimer)(Immunofluorescence Chromatography) Performance Index D...
D-Dimer Detection Reagent(D-Dimer)(Immunofluorescence Chromatography) D-dimer Overview D-Dimer (D...
Combined Detection Reagent Of Troponin I,Myoglobin And Creatine Kinase Isoenzyme Clinical Significan...
Combined Detection Reagent Of Troponin I,Myoglobin And Creatine Kinase Isoenzyme(CTnl/MYO/CK-MB) ...
Heart Type Fatty Acid Binding Protein Detection Reagent (Immunofluorescence Chromatography) Clinical ...